Delisting of Securities of PhaseBio Pharmaceuticals, Inc.; Zovio Inc.; Fast Radius, Inc.; and Kismet Acquisition Three Corp. from The Nasdaq Stock Market
NEW YORK, Dec. 20, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc.’s common stock was suspended on November 3, 2022, and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the common stock of Zovio Inc. Zovio Inc.’s common stock was suspended on November 10, 2022, and has not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the Class A Common Stock and Warrants of Fast Radius, Inc. Fast Radius, Inc.’s securities were suspended on November 18, 2022, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist the Class A Ordinary Shares, warrant, and unit of Kismet Acquisition Three Corp. Kismet Acquisition Three Corp.’s securities were suspended on November 21, 2022, and have not traded on Nasdaq since that time.
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .
-NDAQO-
